ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
4,76
-0,05
(-1,04%)
Geschlossen 12 Juli 10:00PM

Quantum BioPharma Ltd (QNTM) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
4,76
( -1,04% )
Gebot
4,69
Fragen
4,90
Volumen
1.498
Durchschnittliches Volumen (3 Mio.)
$ 14.482
Finanzvolumen
-
4,59 Tagesbereich 4,85
2,85 52-Wochen-Bereich 43,00
Marktkapitalisierung
Unternehmenswert
15,689M
Handelsende
4,81
Handelsbeginn
4,65
Letzte Trade
76
@
4.69
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
-
Nettogewinn (LTM)
-31,16M
Ausgegebene Aktien
6.398.647
Streubesitz (%)
93,17%
Institutioneller Besitz (%)
9,95%
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,41
Kurs-Umsatz-Verhältnis (KUV)
-
Gewinn pro Aktie (EPS)
-8,22
Beta
0,44

Über Quantum BioPharma Ltd

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegener... Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company’s lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada. Mehr anzeigen

Sektor
Health Care
Branche
-
Hauptsitz
Toronto, Canada
Gegründet
1998
Quantum BioPharma Ltd is listed in the Health Care sector of the Canadian Securities Exchange with ticker QNTM. The last closing price for Quantum BioPharma was $4,81. Over the last year, Quantum BioPharma shares have traded in a share price range of $ 2,85 to $ 43,00.

Quantum BioPharma currently has 6.398.647 shares in issue. The market capitalisation of Quantum BioPharma is $30,46 million. Quantum BioPharma has a price to earnings ratio (PE ratio) of -0.41.

QNTM Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.010.2105263157894.755.114.4533784.72345017CS
4-0.77-13.92405063295.536.24.4586875.21109599CS
120.4911.47540983614.2714.754.19146057.86596319CS
26-5.61-54.098360655710.3714.752.85145416.33521982CS
52-18.24-79.304347826123432.8594019.59768412CS
156-0.39-7.572815533985.15522.85850411.28516506CS
260-0.39-7.572815533985.15522.85850411.28516506CS

QNTM - Frequently Asked Questions (FAQ)

What is the current Quantum BioPharma Ltd share price?
The current share price of Quantum BioPharma Ltd is $ 4,76
How many Quantum BioPharma Ltd shares are in issue?
Quantum BioPharma Ltd has 6.398.647 shares in issue
What is the market cap of Quantum BioPharma Ltd?
The market capitalisation of Quantum BioPharma Ltd is CAD 30,46M
What is the 1 year trading range for Quantum BioPharma Ltd share price?
Quantum BioPharma Ltd has traded in the range of $ 2,85 to $ 43,00 during the past year
What is the PE ratio of Quantum BioPharma Ltd?
The price to earnings ratio of Quantum BioPharma Ltd is -0,41
What is the registered address of Quantum BioPharma Ltd?
The registered address for Quantum BioPharma Ltd is 1 Adelaide Street East, Toronto, Ontario, M5C 2V9
What is the Quantum BioPharma Ltd website address?
The website address for Quantum BioPharma Ltd is www.quantumbiopharma.com

QNTM Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen